Standard pharmacological treatment
Preclinical
Standard pharmacological treatment is one of 2 therapeutic programs targeting Occlusion. It is currently in Preclinical.
2
Indications
2
Total Trials
2
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Competition
Competitive Landscape
1 competitor in Occlusion
#DrugCompanyPhaseTrials
1Unfractionated Heparin
GSKPreclinical
Standard pharmacological treatment
UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Posterior Circulation1 trial
Occlusion1 trial
Endovascular Treatment of Chronic Intracranial Artery Occlusion: A Multicenter Randomized Controlled Trial
Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Preclinical·NCT07699003·382 enrolled
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]